Phase 2 study evaluating the efficacy and safety of biomarker-driven therapies in patients with persistent or recurrent rare epithelial ovarian tumours [WO42178] [BOUQUET]

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date15/09/21 → 31/12/27

Keywords

  • Epithelial ovarian tumours
  • Solid tumours
  • Cancer therapy
  • Clinical trial

Clinical Trial Phase

  • Phase II